477 related articles for article (PubMed ID: 11654182)
1. International research agreement leads to new U.S. guidelines.
Maloney DM
Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
[No Abstract] [Full Text] [Related]
2. Proposal for a good clinical practice directive.
European Commission
Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
[No Abstract] [Full Text] [Related]
3. European directive on clinical trials.
Bull Med Ethics; 1999 May; No. 148():3-4. PubMed ID: 11657983
[No Abstract] [Full Text] [Related]
4. The federal policy for the protection of human subjects.
Porter JP
IRB; 1991; 13(5):8-9. PubMed ID: 11651250
[No Abstract] [Full Text] [Related]
5. Collaborative research involving human subjects: a survey of researchers using international single project assurances.
Wichman A; Smith J; Mills D; Sandler AL
IRB; 1997; 19(1):1-6. PubMed ID: 11654738
[No Abstract] [Full Text] [Related]
6. Harm to research subjects will now lead to new federal regulations.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):1-3. PubMed ID: 11654161
[No Abstract] [Full Text] [Related]
7. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
Gordon B; Prentice E
IRB; 1997; 19(2):8-11. PubMed ID: 11655323
[No Abstract] [Full Text] [Related]
8. The FDA's enforcement of IRBs and patient informed consent.
Kelsey FO
Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
[No Abstract] [Full Text] [Related]
9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use.
Int Dig Health Legis; 1997; 48(2):231-4. PubMed ID: 11656783
[No Abstract] [Full Text] [Related]
10. Guidelines for confidentiality in research on AIDS.
Bayer R; Levine C; Murray TH
IRB; 1984; 6(6):1-7. PubMed ID: 11649192
[No Abstract] [Full Text] [Related]
11. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
12. Trends in gene therapy regulation.
Lecomte V; Taylor A
Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
[No Abstract] [Full Text] [Related]
13. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
14. A look at the bioresearch monitoring program: the agency perspective.
Brisson EL
Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
[No Abstract] [Full Text] [Related]
15. Can (or should) the IRB assume the FDA's functions at early stages of the IND process?
Levine RJ
IRB; 1981 Dec; 3(10):4-5. PubMed ID: 11649414
[No Abstract] [Full Text] [Related]
16. Reviewing subject recruitment: new rules from Rockville.
McMahon FG
IRB; 1988; 10(3):6-7. PubMed ID: 11651911
[No Abstract] [Full Text] [Related]
17. The Food and Drug Administration's role in the protection of human subjects.
Nightingale SL
IRB; 1983; 5(1):6-9. PubMed ID: 11649511
[No Abstract] [Full Text] [Related]
18. The history of institutional review boards.
Sherman M; Van Vleet JD
Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
[No Abstract] [Full Text] [Related]
19. Federal report says protection of human subjects is threatened by numerous factors.
Maloney DM
Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
[No Abstract] [Full Text] [Related]
20. Divide and rule.
Nicholson RH
Hastings Cent Rep; 1992; 22(4):5. PubMed ID: 11643019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
